Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

ShedRx vs WellMedr

By GLP-1 ScorecardUpdated

ShedRx
Site position #3

Higher grade

WellMedr
Site position #221

Lower grade

Score comparison

ShedRx has the higher recorded score — 87/100 to 63.2/100.

ShedRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Shed combines compounded injections and branded Wegovy/Zepbound options with coaching; compare longer-plan supply, fees and guarantee rules before committing.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueShedRx +26
84
58
Dose & formulationShedRx +22
96
74
Clinical oversightShedRx +13
84
71
Labs & monitoringShedRx +26
84
58
FulfillmentShedRx +26
88
62
Contract termsShedRx +41
85
44
ShedRx · top barWellMedr · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricShedRxWellMedr
WeighScore87/10063.2/100
GradeB+C
Site position#3#221
Semaglutide$199/moAdvertised from $49/month; selected upfront total, plan term and renewal amount need confirmation
Tirzepatide$299/moAdvertised from $89/month; selected upfront total, plan term and renewal amount need confirmation
CoverageAll 50 statesGeneral service page lists all 50 states, DC, Puerto Rico and Guam; exact medication, clinical eligibility and pharmacy fulfillment remain conditional
Brand-name accessYesYes
Oral / sublingualYesYes
ShedRx

Site position #3 · B+

Strengths

  • Published injection plans plus other formulation and branded prescribing options
  • One-month injection prices listed at $199 semaglutide / $299 tirzepatide
  • Terms describe monthly coaching and name six possible pharmacy partners

What to consider

  • Six- and twelve-month plans specify 24 and 48 weeks of medication
  • The 120-day promise has first-time-user and participation requirements and does not cancel a longer plan
  • Branded pages display conflicting $99/$125 membership charges, with medication separate
  • Actual clinician/pharmacy assignment and the applicable minimum term need confirmation
WellMedr

Site position #221 · C

Strengths

  • Publishes separate descriptions of 21-day billing and fully prepaid three-, six- and twelve-month plans
  • The refund policy provides detailed renewal and unused-prepayment rules, although important provisions conflict with the Terms
  • Current documents name possible pharmacy partners, including Logos, Emerald and Center City; the assigned facility still needs confirmation
  • The safety page distinguishes compounded preparations from FDA-approved products rather than treating shared ingredients as proof of equivalence

What to consider

  • Starting $49 and $89 advertisements do not establish the total due today, renewal amount or usable prescription supply; confirm whether membership and medication are separate charges
  • Four-week shipping is not the billing calendar; the separately described 21-day plan can generate more frequent charges
  • The refund policy accepts cancellation before a charge is submitted, while the Terms require two days’ notice and allow early renewal processing
  • Unused-prepayment allocation in the refund policy conflicts with discretionary partial refunds, medication-plan cancellation windows and a nonrefundable first membership month in the Terms; no legal priority is established
  • The ninety-day results-refund promise conflicts with policy language denying a results guarantee; clarify the selected written agreement
  • The current directory does not establish an available oral or microdose GLP-1 purchase; the homepage labels microdose Coming soon
  • Current documents do not identify the assigned clinical practice, clinician, dispenser or physical compounder; general service coverage does not guarantee every preparation

Featured provider

ShedRx

ShedRx scores 87/100 (B+). Shed combines compounded injections and branded Wegovy/Zepbound options with coaching; compare longer-plan supply, fees and guarantee rules before committing.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard